Cargando…

Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism

Tumor cells must activate specific transporters to meet their increased glutamine metabolic demands. Relative to other glutamine transporters, the ASC family transporter 2 (ASCT2, also called SLC1A5) is profoundly elevated in a wide spectrum of human cancers to coordinate metabolic reprogramming and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, J, Xiao, D, Zhao, Z, Ren, P, Li, C, Hu, Y, Shi, J, Su, H, Wang, L, Liu, H, Li, B, Gao, P, Qing, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541711/ https://www.ncbi.nlm.nih.gov/pubmed/28692032 http://dx.doi.org/10.1038/oncsis.2017.59

Ejemplares similares

Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells
por: Wang, Wenbin, et al.
Publicado: (2022)

ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma
por: Marshall, A D, et al.
Publicado: (2017)

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2018)

Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth
por: Ye, Jianxin, et al.
Publicado: (2018)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
por: Luo, Yijun, et al.
Publicado: (2020)

Pharmacological Blockade of ASCT2-dependent Glutamine Transport Leads To Anti-tumor Efficacy in Preclinical Models
por: Schulte, Michael L., et al.
Publicado: (2018)

Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development
por: Wang, Qian, et al.
Publicado: (2015)

Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells
por: Polet, Florence, et al.
Publicado: (2016)

Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5
por: Scopelliti, Amanda J, et al.
Publicado: (2018)

Identification and Functional Analysis of Epigenetically Silenced MicroRNAs in Colorectal Cancer Cells
por: Yan, Hongli, et al.
Publicado: (2011)

NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence via the induction of ASCT2
por: Ding, Mingchao, et al.
Publicado: (2020)

MicroRNA-137 Drives Epigenetic Reprogramming in the Adult Amygdala and Behavioral Changes after Adolescent Alcohol Exposure
por: Kyzar, Evan J., et al.
Publicado: (2019)

Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
por: Yu, Xiaodi, et al.
Publicado: (2019)

Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties
por: Taube, Joseph H., et al.
Publicado: (2013)

MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2
por: Feng, Qiong, et al.
Publicado: (2017)

MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2
por: Feng, Qiong, et al.
Publicado: (2021)

Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia
por: Wright, C, et al.
Publicado: (2016)

Ag120-Mediated Inhibition of ASCT2-Dependent Glutamine Transport has an Anti-Tumor Effect on Colorectal Cancer Cells
por: Yu, Wei, et al.
Publicado: (2022)

A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer
por: Lyu, Xiao-Dan, et al.
Publicado: (2023)

A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors
por: Isosaka, Mai, et al.
Publicado: (2015)

Epigenetic Silencing of MicroRNA-126 Promotes Cell Growth in Marek’s Disease
por: Gennart, Isabelle, et al.
Publicado: (2021)

Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition
por: Huang, Yu-Chuan, et al.
Publicado: (2016)

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
por: van Geldermalsen, M, et al.
Publicado: (2016)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
por: Wang, Jiali, et al.
Publicado: (2022)

ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
por: Zhang, Ze, et al.
Publicado: (2019)

LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
por: Dias, Francisca, et al.
Publicado: (2021)

miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
por: Luo, Meiying, et al.
Publicado: (2018)

Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas
por: Naraparaju, Koumudi, et al.
Publicado: (2016)

Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review
por: Ramzan, Farha, et al.
Publicado: (2021)

Silencing microRNA by interfering nanoparticles in mice
por: Su, Jie, et al.
Publicado: (2011)

microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP
por: Li, Xiaodi, et al.
Publicado: (2017)

Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
por: Guo, Jing, et al.
Publicado: (2021)

Epigenetics, microRNA, and addiction
por: Kenny, Paul J.
Publicado: (2014)

The Differential DNA Hypermethylation Patterns of microRNA-137 and microRNA-342 Locus in Early Colorectal Lesions and Tumours
por: Kashani, Elham, et al.
Publicado: (2019)

Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment
por: Li, Pu, et al.
Publicado: (2015)

The Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic Diseases
por: Sethupathy, Praveen
Publicado: (2016)

Epigenetic Activation of ASCT2 in the Hippocampus Contributes to Depression-Like Behavior by Regulating D-Serine in Mice
por: Wang, Jiesi, et al.
Publicado: (2017)

Mecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence and Tumor Progression via Relieving the Suppression of c-Met
por: Chen, Tao, et al.
Publicado: (2017)

TRIM25 contributes to the malignancy of acute myeloid leukemia and is negatively regulated by microRNA-137
por: Wang, Sheng, et al.
Publicado: (2020)

microRNAs: the art of silencing in the ear
por: Rudnicki, Anya, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qcrdssapuvd89a3oj2brm5cjml